Considering that proteins LMP2, PSME1 and PSME2 are all components of proteasome complex and participate in proteasome protein decomposition and immune system biological processes, we decided to select proteins LMP2, PSME1 and PSME2 for NSCLC biomarker exploration. This evidence concerns the gene PSME2 and non-small cell lung carcinoma.